公司資料
Marinus 股價、新聞與催化劑
- 股票代碼:
- MRNS
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for MRNS.
公司概覽
業務概覽
Marinus is a neuroscience company focused on seizure and neuropsychiatric disorders with a commercial and development mix. Its story has been shaped by efforts to turn CNS programs into durable value.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Marinus sits in specialty neuroscience biopharma.
商業模式特徵
The business depends on product adoption, pipeline progress, and the ability to stabilize a concentrated CNS story.
生技產業定位
Marinus is a catalyst-sensitive CNS name whose stock reacts to both commercial and clinical updates.
未來催化劑
- Marinus’s catalyst set is centered on ZTALMY and any strategic update that clarifies the company’s remaining value after the epilepsy program. The story is now more about what the company becomes next than about a broad pipeline.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。